{
    "organizations": [],
    "uuid": "ab7be777130f9412493082c2addef6963f885f34",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bone-therapeutics-announces-privat/brief-bone-therapeutics-announces-private-placement-of-convertible-bonds-idUSFWN1QP010",
    "ord_in_thread": 0,
    "title": "BRIEF-Bone Therapeutics Announces Private Placement Of Convertible Bonds",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - BONE THERAPEUTICS:\n* REG-BONE THERAPEUTICS ANNOUNCES PRIVATE PLACEMENT OF CONVERTIBLE BONDS\n* ‍BOOK BUILDING PROCESS COMMENCED YESTERDAY, 6 MARCH 2018, AFTER MARKET CLOSE​\n* ‍RESULTS OF OFFERING WILL BE ANNOUNCED AS SOON AS POSSIBLE AFTER CLOSING OF BOOK BUILDING​\n* ‍TRADING SHARES ON EURONEXT BRUSSELS AND EURONEXT PARIS WILL BE SUSPENDED DURING BOOK BUILDING PERIOD​\n* ‍TRADING IN STOCK IS EXPECTED TO RESUME FOLLOWING PUBLICATION OF RESULTS OF OFFERING​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-07T14:24:00.000+02:00",
    "crawled": "2018-03-08T17:15:38.065+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "bone",
        "therapeutic",
        "therapeutic",
        "announces",
        "private",
        "placement",
        "convertible",
        "bond",
        "building",
        "process",
        "commenced",
        "yesterday",
        "march",
        "market",
        "offering",
        "announced",
        "soon",
        "possible",
        "closing",
        "book",
        "share",
        "euronext",
        "brussels",
        "euronext",
        "paris",
        "suspended",
        "book",
        "building",
        "stock",
        "expected",
        "resume",
        "following",
        "publication",
        "result",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}